[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease]

Gastroenterol Hepatol. 2003 May;26(5):312-24. doi: 10.1016/s0210-5705(03)70365-3.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / analysis
  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Antibodies, Fungal / analysis
  • Antibodies, Fungal / immunology*
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology*
  • Biomarkers
  • Colitis / diagnosis
  • Colitis / immunology
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / genetics
  • Colitis, Ulcerative / immunology
  • Colitis, Ulcerative / surgery
  • Colonic Pouches
  • Crohn Disease / diagnosis
  • Crohn Disease / genetics
  • Crohn Disease / immunology
  • Genetic Predisposition to Disease
  • Humans
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / immunology*
  • Phenotype
  • Postoperative Complications
  • Prevalence
  • Proctocolectomy, Restorative
  • Prognosis
  • Risk
  • Saccharomyces cerevisiae / immunology*
  • Sensitivity and Specificity

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Fungal
  • Biomarkers